Machine signal
Active cluster sell — 5 distinct insiders, $194.9K, window ends Aug 31, 2026.
Figures computed from official regulatory filings — .
Analysttarget 18.83 USD (+636%) · consensus 4.83/5 · 6 buy · 0 hold · 0 sell
Ownershipinsiders 12.87% · institutions 31.01% · short 9.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for GENELUX Corp only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer. It also offers CHOICE, a technology and discovery and development platform; and developed an extensive library of isolated and engineered oncolytic VACV immunotherapeutic product candidates. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
10 buys139 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Yu Yong | Sell | $26.7K | SEC | ||
| Cappello Joseph | Sell | $28.1K | SEC | ||
| Zindrick Thomas | Sell | $91.9K | SEC | ||
| Zindrick Thomas | Sell | $8.9K | SEC | ||
| Yu Yong | Sell | $1.9K | SEC | ||
| Cappello Joseph | Sell | $1.9K | SEC | ||
| Smither John W | Sell | $34.9K | SEC | ||
| Zindrick Thomas | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Mirabelli Mary | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Smither John W | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Smither John W | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Tyree James L | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Thomas John | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Pulisic Matthew | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Cappello Joseph | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Thomas John | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Yu Yong | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Mirabelli Mary | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Tyree James L | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Groen Eric | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Smalling Ralph | Sell | $562.6 | SEC | ||
| Thomas John | Sell | $29.8K | SEC | ||
| Yu Yong | Sell | $1.8K | SEC | ||
| Smalling Ralph | Sell | $804.5 | SEC | ||
| Zindrick Thomas | Sell | $8.2K | SEC |